SERA

MKT CAP:$79M

Sera Prognostics, Inc.

Market Cap

$79M

Healthcare·Medical - Diagnostics & Research·🇺🇸 United States·NASDAQ

Healthcare·Medical·🇺🇸·NASDAQ

Stock Price

$2.23-$0.77 (-25.67%)

Apr 21, 2026

Company Details

Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spo...

CEO

Zhenya Lindgardt

IPO Date

Jul 15, 2021

Website

seraprognostics.com

Key Metrics TTM

Revenue

$81.0K

+5.2% YoY

Net Income

-$32M

EPS (Diluted)

-$0.68

Free Cash Flow

-$26M

Revenue / Share

$0.00

Gross Margin

-102.5%

Operating Margin

-45066.7%

Net Margin

-39417.3%

FCF Margin

-32529.6%

P/S

970.9x

P/E

—

Earnings Reports

Q1 2026

May 6, 2026

PENDING

FY 2025

Mar 18, 2026

$81.0K+5.2%EPS -$0.67

Q4 2025

Mar 18, 2026

$10.0K-58.3%EPS -$0.16

Q3 2025

Nov 13, 2025

$16.0K-44.8%EPS -$0.16

Q2 2025

Aug 6, 2025

$17.0K-29.2%EPS -$0.16

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q1 22	$38.0K	$18.0K	-$12M
Q2 22	$78.0K	$22.0K	-$12M
Q3 22	$87.0K	$29.0K	-$11M
Q4 22	$65.0K	$6.0K	-$10M
Q1 23	$100.0K	$38.0K	-$11M
Q2 23	$123.0K	$43.0K	-$11M
Q3 23	$42.0K	-$2.0K	-$8M
Q4 23	$41.0K	-$195.0K	-$9M
Q1 24	$0	-$17.0K	-$9M
Q2 24	$24.0K	$4.0K	-$9M
Q3 24	$29.0K	$16.0K	-$9M
Q4 24	$24.0K	-$8.0K	-$9M
Q1 25	$38.0K	-$2.0K	-$9M
Q2 25	$17.0K	-$24.0K	-$9M
Q3 25	$16.0K	-$25.0K	-$9M
Q4 25	$10.0K	-$32.0K	-$9M

Valuation

Quarter	P/S	P/E
Q1 22	1039.2x	—
Q2 22	405.1x	—
Q3 22	226.2x	—
Q4 22	176.0x	—
Q1 23	367.3x	—
Q2 23	269.5x	—
Q3 23	186.6x	—
Q4 23	569.6x	—
Q1 24	1498.0x	—
Q2 24	1892.3x	—
Q3 24	2816.3x	—
Q4 24	3676.0x	—
Q1 25	1086.1x	—
Q2 25	1076.4x	—
Q3 25	1575.3x	—
Q4 25	1999.3x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 22	-$10M	-$10M
Q2 22	-$9M	-$9M
Q3 22	-$9M	-$9M
Q4 22	-$7M	-$7M
Q1 23	-$5M	-$5M
Q2 23	-$8M	-$8M
Q3 23	-$8M	-$8M
Q4 23	-$7M	-$7M
Q1 24	$5M	$4M
Q2 24	-$6M	-$6M
Q3 24	-$7M	-$7M
Q4 24	-$6M	-$6M
Q1 25	-$8M	-$8M
Q2 25	-$5M	-$6M
Q3 25	-$6M	-$7M
Q4 25	-$6M	-$6M

Capital Expenditures

Quarter	CapEx
Q1 22	$7.0K
Q2 22	$219.0K
Q3 22	$372.0K
Q4 22	$193.0K
Q1 23	$39.0K
Q2 23	$47.0K
Q3 23	$26.0K
Q4 23	$16.0K
Q1 24	$712.0K
Q2 24	$7.0K
Q3 24	$321.0K
Q4 24	$61.0K
Q1 25	$3.0K
Q2 25	$281.0K
Q3 25	$112.0K
Q4 25	$330.0K

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 22	+192.3%	+104.3%
Q2 22	+290.0%	+59.8%
Q3 22	+278.3%	+19.1%
Q4 22	+150.0%	-16.6%
Q1 23	+163.2%	-7.4%
Q2 23	+57.7%	-2.0%
Q3 23	-51.7%	-27.0%
Q4 23	-36.9%	-16.2%
Q1 24	-100.0%	-20.4%
Q2 24	-80.5%	-19.9%
Q3 24	-31.0%	+8.1%
Q4 24	-41.5%	+7.5%
Q1 25	—	+2.1%
Q2 25	-29.2%	+0.6%
Q3 25	-44.8%	+1.2%
Q4 25	-58.3%	-5.1%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 22	$1M	3215.8%
Q2 22	$1M	1556.4%
Q3 22	$1M	1469.0%
Q4 22	$1M	2063.1%
Q1 23	$1M	1304.0%
Q2 23	$0	0.0%
Q3 23	$0	0.0%
Q4 23	$1M	3285.4%
Q1 24	$2M	—
Q2 24	$2M	8429.2%
Q3 24	$2M	5793.1%
Q4 24	$2M	6737.5%
Q1 25	$1M	3928.9%
Q2 25	$1M	7905.9%
Q3 25	$1M	7837.5%
Q4 25	$1M	10190.0%

OpEx Breakdown

Quarter	R&D	G&A	S&M	SG&A
Q1 22	$3M	$5M	$4M	—
Q2 22	$3M	$4M	$4M	—
Q3 22	$4M	$4M	$3M	—
Q4 22	$3M	$4M	$3M	—
Q1 23	$4M	$4M	$3M	—
Q2 23	$4M	$5M	$3M	—
Q3 23	$4M	$3M	$1M	—
Q4 23	$4M	—	—	$5M
Q1 24	$4M	$4M	$1M	—
Q2 24	$4M	$4M	$1M	—
Q3 24	$4M	$4M	$1M	—
Q4 24	$3M	$4M	$2M	—
Q1 25	$3M	$4M	$1M	—
Q2 25	$3M	$4M	$2M	—
Q3 25	$3M	$4M	$2M	—
Q4 25	$3M	$4M	$2M	—

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 22	$64M	$43M	$108M
Q2 22	$54M	$53M	$107M
Q3 22	$39M	$50M	$89M
Q4 22	$30M	$53M	$83M
Q1 23	$27M	$44M	$71M
Q2 23	$32M	$32M	$64M
Q3 23	$10M	$36M	$46M
Q4 23	$4M	$45M	$49M
Q1 24	$4M	$49M	$53M
Q2 24	$5M	$46M	$51M
Q3 24	$3M	$47M	$50M
Q4 24	$4M	$42M	$46M
Q1 25	$5M	$41M	$46M
Q2 25	$5M	$35M	$40M
Q3 25	$4M	$39M	$43M
Q4 25	$4M	$35M	$39M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q1 22	31M	+0.3%	+1.0%
Q2 22	31M	+0.5%	+1.4%
Q3 22	31M	+0.2%	+23.6%
Q4 22	31M	+0.0%	+1.0%
Q1 23	31M	+0.0%	+0.7%
Q2 23	31M	+0.2%	+0.4%
Q3 23	31M	+0.7%	+0.9%
Q4 23	31M	+0.4%	+1.3%
Q1 24	32M	+2.6%	+3.9%
Q2 24	33M	+2.2%	+6.0%
Q3 24	34M	+1.8%	+7.1%
Q4 24	34M	+1.2%	+8.0%
Q1 25	42M	+23.7%	+30.3%
Q2 25	49M	+16.9%	+49.0%
Q3 25	50M	+0.9%	+47.7%
Q4 25	50M	+0.9%	+47.3%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q1 22	$336	113
Q2 22	$690	113
Q3 22	$770	113
Q4 22	$730	89
Q1 23	$1.1K	89
Q2 23	$1.4K	89
Q3 23	$472	89
Q4 23	$719	57
Q1 24	$0	57
Q2 24	$421	57
Q3 24	$509	57
Q4 24	$375	64
Q1 25	$594	64
Q2 25	$266	64
Q3 25	$250	64
Q4 25	$20	500

Revenue / Employee